Singapore markets closed
  • Straits Times Index

    3,269.27
    -32.69 (-0.99%)
     
  • Nikkei

    28,546.98
    +727.65 (+2.62%)
     
  • Hang Seng

    20,175.62
    +93.19 (+0.46%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • BTC-USD

    24,183.36
    +40.15 (+0.17%)
     
  • CMC Crypto 200

    575.36
    +4.08 (+0.71%)
     
  • S&P 500

    4,272.28
    +65.01 (+1.55%)
     
  • Dow

    33,715.46
    +378.79 (+1.14%)
     
  • Nasdaq

    13,022.81
    +242.90 (+1.90%)
     
  • Gold

    1,816.10
    +8.90 (+0.49%)
     
  • Crude Oil

    91.86
    -2.48 (-2.63%)
     
  • 10-Yr Bond

    2.8510
    -0.0370 (-1.28%)
     
  • FTSE Bursa Malaysia

    1,506.19
    +0.63 (+0.04%)
     
  • Jakarta Composite Index

    7,129.28
    -31.11 (-0.43%)
     
  • PSE Index

    6,699.66
    +18.98 (+0.28%)
     

Cue Health to Present at Upcoming Investor Conferences

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, June 01, 2022--(BUSINESS WIRE)--Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following conferences:

  • 43rd Annual Goldman Sachs Global Healthcare Conference
    Presenting on Wednesday, June 15, 2022 at 6:20 p.m. Eastern Time at the Terranea Resort in Rancho Palos Verdes. The live audio webcast and replay of the presentation may be accessed for 90 days on the "Investor Relations" section of the company’s website at: www.cuehealth.com.

  • 7th Annual Cowen FutureHealth Conference
    Presenting on Wednesday, June 22, 2022 at 1:35 p.m. Eastern Time

About Cue Health

Cue Health (Nasdaq: HLTH) is a healthcare technology company that makes it easy for individuals to access health information and places diagnostic information at the center of care. Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision. Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, regulatory approval from India’s Central Drugs Standard Control Organization, and PSAR authorization from Singapore’s Health Sciences Authority. Cue Health was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220601005597/en/

Contacts

ICR Westwicke
Caroline Corner
ir@cuehealth.com
(415) 202-5678

Cue Health
press@cuehealth.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting